Country-Contextualised IMP Management.
A proprietary five-layer decision framework for clinical trial expansion into African corridors.
Africa is not an execution problem waiting to be solved. It is a decision problem waiting to be structured. Sponsors who approach Africa through a rigorous Go/No-Go decision framework — rather than defaulting to operational assumptions — achieve faster entry, lower rework costs, and significantly stronger governance outcomes.
CCIM™ evaluates expansion readiness across five sequential decision layers. Each layer must be fully assessed before a responsible Go/No-Go decision can be made.
The framework sits above CRO execution and logistics vendors — it focuses on decision readiness, risk clarity, and economic rationale. Only when all five layers are understood can sponsors make a responsible expansion decision.
Not every program is suitable for Africa expansion — understand yours first.
The first step is to evaluate whether the program's characteristics can tolerate the operational variability inherent in emerging-market corridors. This is not a judgment on Africa — it is a scientific and operational fitness assessment that must be conducted for any complex trial geography.
The question is not whether Africa works — but whether your corridor works.
Each corridor must be analysed end-to-end: origin manufacturing → export airport → international transport → import customs → regional depot → clinical site. The viability of a specific corridor determines the operational foundation of the entire trial.
Corridor Classification
Disruptions will occur — the question is how fast and clearly decisions get made.
Clinical Trial Supply disruptions are inevitable in any emerging-market corridor. Operational success depends not on preventing all deviations, but on having a governance structure that enables fast, clear, documented decisions when they occur. CCIM™ defines CTS as a Critical-to-Quality (CtQ) system, aligned with ICH E6(R3) expectations for sponsor oversight.
Acknowledge what cannot be eliminated — before it becomes a crisis.
Even the best-designed supply chains cannot eliminate all risks. Responsible expansion requires that residual risks be formally acknowledged, documented, and accepted at the appropriate leadership level — before operational commitments are made.
Africa expansion must demonstrate tangible value — not just diversity optics.
Beyond operational feasibility, sponsors must understand the strategic and economic rationale for expansion. Three major economic drivers support a Go decision:
CCIM™ produces a structured Decision Pack for sponsor leadership — the evidence base for a defensible Go/No-Go decision that aligns clinical operations, supply chain, regulatory affairs, and executive leadership before any operational commitment is made.
Rêve Solutions partners with sponsors at the decision layer — providing the regulatory intelligence, corridor expertise, governance design, and strategic ROI analysis that turns Africa from a question mark into a confident strategic commitment.